Actinic Keratosis Treatment Market Report

Global and Region Actinic Keratosis Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：156
  • REPORT CODE：GMM895951
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Actinic keratosis (AK) is a form of skin cancer and it is also known as solar keratosis. This indication tends to affect the sun-exposed parts of the skin such as face, bald scalp, lips, and the back of the hands among others. As a result of the exposure, the skin tends to become rough, uneven and display a warty look.

    The report details the trend, potential and market size of Actinic Keratosis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Actinic Keratosis Treatmentmarket, defines the market attractiveness level of Actinic Keratosis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Actinic Keratosis Treatment industry, describes the types of Actinic Keratosis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Actinic Keratosis Treatment market and the development prospects and opportunities of Actinic Keratosis Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Actinic Keratosis Treatment market in Chapter 13.

    By Player:

    • Horizon Pharma

    • DUSA Pharmaceuticals

    • Aqua Pharmaceuticals

    • Nuvo Research

    • Valeant Pharmaceuticals

    • 3M Pharmaceuticals

    • Galderma

    • Tolmar Pharmaceuticals

    • Fougera

    • Novartis

    • LEO Pharma

    By Type:

    • 5-fluorouracil (5-FU) cream

    • Imiquimod cream

    • Diclofenac sodium gel

    • Ingenol mebutate gel

    • Others

    By End-User:

    • Hospitals

    • Private Dermatologist Office and Clinics

    • Oncology Centers

    • Ambulatory Surgical Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Actinic Keratosis Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Actinic Keratosis Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Actinic Keratosis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Actinic Keratosis Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Actinic Keratosis Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Actinic Keratosis Treatment Consumption (2017-2022)

    • 7.2 United States Actinic Keratosis Treatment Consumption (2017-2022)

    • 7.3 Europe Actinic Keratosis Treatment Consumption (2017-2022)

    • 7.4 China Actinic Keratosis Treatment Consumption (2017-2022)

    • 7.5 Japan Actinic Keratosis Treatment Consumption (2017-2022)

    • 7.6 India Actinic Keratosis Treatment Consumption (2017-2022)

    • 7.7 South Korea Actinic Keratosis Treatment Consumption (2017-2022)

    8 Region and Country-wise Actinic Keratosis Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    • 8.4 China Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    • 8.6 India Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Actinic Keratosis Treatment Consumption Forecast (2022-2028)

    9 Global Actinic Keratosis Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Actinic Keratosis Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 5-fluorouracil (5-FU) cream Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Imiquimod cream Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Diclofenac sodium gel Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Ingenol mebutate gel Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Actinic Keratosis Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Private Dermatologist Office and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Oncology Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Actinic Keratosis Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Actinic Keratosis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 5-fluorouracil (5-FU) cream Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Imiquimod cream Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Diclofenac sodium gel Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Ingenol mebutate gel Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Actinic Keratosis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Private Dermatologist Office and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Actinic Keratosis Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Actinic Keratosis Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Actinic Keratosis Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Actinic Keratosis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Actinic Keratosis Treatment Market Competitive Analysis

    • 14.1 Horizon Pharma

      • 14.1.1 Horizon Pharma Company Details

      • 14.1.2 Horizon Pharma Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Horizon Pharma Actinic Keratosis Treatment Product and Service

    • 14.2 DUSA Pharmaceuticals

      • 14.2.1 DUSA Pharmaceuticals Company Details

      • 14.2.2 DUSA Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • 14.3 Aqua Pharmaceuticals

      • 14.3.1 Aqua Pharmaceuticals Company Details

      • 14.3.2 Aqua Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Aqua Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • 14.4 Nuvo Research

      • 14.4.1 Nuvo Research Company Details

      • 14.4.2 Nuvo Research Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Nuvo Research Actinic Keratosis Treatment Product and Service

    • 14.5 Valeant Pharmaceuticals

      • 14.5.1 Valeant Pharmaceuticals Company Details

      • 14.5.2 Valeant Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Valeant Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • 14.6 3M Pharmaceuticals

      • 14.6.1 3M Pharmaceuticals Company Details

      • 14.6.2 3M Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 3M Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • 14.7 Galderma

      • 14.7.1 Galderma Company Details

      • 14.7.2 Galderma Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Galderma Actinic Keratosis Treatment Product and Service

    • 14.8 Tolmar Pharmaceuticals

      • 14.8.1 Tolmar Pharmaceuticals Company Details

      • 14.8.2 Tolmar Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Tolmar Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • 14.9 Fougera

      • 14.9.1 Fougera Company Details

      • 14.9.2 Fougera Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Fougera Actinic Keratosis Treatment Product and Service

    • 14.10 Novartis

      • 14.10.1 Novartis Company Details

      • 14.10.2 Novartis Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis Actinic Keratosis Treatment Product and Service

    • 14.11 LEO Pharma

      • 14.11.1 LEO Pharma Company Details

      • 14.11.2 LEO Pharma Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 LEO Pharma Actinic Keratosis Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Actinic Keratosis Treatment

    • Figure Actinic Keratosis Treatment Picture

    • Table Global Actinic Keratosis Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Actinic Keratosis Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Actinic Keratosis Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Actinic Keratosis Treatment Consumption by Country (2017-2022)

    • Figure United States Actinic Keratosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Actinic Keratosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Actinic Keratosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Actinic Keratosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Actinic Keratosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Actinic Keratosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Actinic Keratosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Actinic Keratosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Actinic Keratosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Actinic Keratosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Actinic Keratosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Actinic Keratosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Actinic Keratosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 5-fluorouracil (5-FU) cream Consumption and Growth Rate (2017-2022)

    • Figure Global Imiquimod cream Consumption and Growth Rate (2017-2022)

    • Figure Global Diclofenac sodium gel Consumption and Growth Rate (2017-2022)

    • Figure Global Ingenol mebutate gel Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Private Dermatologist Office and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global 5-fluorouracil (5-FU) cream Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Imiquimod cream Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diclofenac sodium gel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ingenol mebutate gel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Private Dermatologist Office and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Actinic Keratosis Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Actinic Keratosis Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Horizon Pharma (Foundation Year, Company Profile and etc.)

    • Table Horizon Pharma Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Pharma Actinic Keratosis Treatment Product and Service

    • Table DUSA Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table DUSA Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table DUSA Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • Table Aqua Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Aqua Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aqua Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • Table Nuvo Research (Foundation Year, Company Profile and etc.)

    • Table Nuvo Research Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nuvo Research Actinic Keratosis Treatment Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • Table 3M Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table 3M Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • Table Galderma (Foundation Year, Company Profile and etc.)

    • Table Galderma Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma Actinic Keratosis Treatment Product and Service

    • Table Tolmar Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Tolmar Pharmaceuticals Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tolmar Pharmaceuticals Actinic Keratosis Treatment Product and Service

    • Table Fougera (Foundation Year, Company Profile and etc.)

    • Table Fougera Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fougera Actinic Keratosis Treatment Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Actinic Keratosis Treatment Product and Service

    • Table LEO Pharma (Foundation Year, Company Profile and etc.)

    • Table LEO Pharma Actinic Keratosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table LEO Pharma Actinic Keratosis Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US